Lumos Pharma Inc
(NAS:LUMO)
$
3.94
0.1 (2.6%)
Market Cap: 32.01 Mil
Enterprise Value: 14.68 Mil
PE Ratio: 0
PB Ratio: 3.10
GF Score: 47/100 NewLink Genetics Corp at Bank of America Merrill Lynch Health Care Conference Transcript
May 16, 2019 / 03:40PM GMT
Release Date Price:
$14.58
Alec Warren Stranahan
BofA Merrill Lynch, Research Division - Research Analyst
I think we can get the session started. My name is Alec Stranahan, I'm an associate on Ying Huang's team at Bank of America, covering large-cap biotech. I have the pleasure today of introducing Dr. Charles Link, Co-Founder and CEO of NewLink Genetics. Welcome to the conference.
Charles J. Link
NewLink Genetics Corporation - Co-Founder, Chairman, CEO & Chief Scientific Officer
Thank you.
Alec Warren Stranahan
BofA Merrill Lynch, Research Division - Research Analyst
And he'll start with an introduction to the company, go through the slides, and then we'll open it up for Q&A.
Charles J. Link
NewLink Genetics Corporation - Co-Founder, Chairman, CEO & Chief Scientific Officer
Well, thank you for having us here at the conference. My slides are not advancing. Okay. I will be making some forward-looking statements today so I refer you to the appropriate regulatory documents.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot